324020-83-9Relevant academic research and scientific papers
(5-Nitro-2-pyridyl) 1-thio-β-D-glucopyranoside as a stable and reactive acceptor
Pastuch,Wandzik,Szeja
, p. 9923 - 9926 (2000)
The title compound was synthesised and studied in several glycosylation procedures as an acceptor. Presented experiments indicate its value as a very stable, effective 'latent' glycosylating agent. (C) 2000 Elsevier Science Ltd.
Novel thioglycosyl analogs of glycosyltransferase substrates as antiviral compounds against classical swine fever virus and hepatitis C virus
Pastuch-Gawolek, Gabriela,Chaubey, Binay,Szewczyk, Boguslaw,Krol, Ewelina
, p. 247 - 262 (2017/06/13)
Hepatitis C virus (HCV) and classical swine fever virus (CSFV) are important pathogens for which new therapeutic approaches are in high demand. Herein, we report the synthesis of newly designed thioglycosyl analogs of glycosyltransferase substrates which were evaluated using cell-based assays for cytotoxicity and antiviral activity against both viruses. The antiviral activity of synthesized compounds against CSFV and HCV was confirmed using pseudo-plaque reduction assays where a significant arrest of viral growth was observed in the presence of selected compounds. We showed that compounds 13 and 14 exerted the most significant inhibitory effect on in vitro CSFV and HCV infections in the series. Glycoconjugates 13 and 14 not only inhibited both viral propagation with IC50 values in low micromolar range, but efficiently suppressed the production of viral proteins in a dose-dependent manner. In addition, studies using in vitro HCV infection and replication models have shown that both compounds are able to significantly reduce viral genomic replication. We demonstrated that compounds 13 and 14 showed a strong inhibition, up to 90% of replication which inscribe them in the promising alternative approach for the development of new anti-CSFV and anti-HCV drugs.
